Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   A terminal alpha 3-galactose modification regulates an E3 ubiquitin ligase subunit in Toxoplasma gondii
  2. Mandalasi, Msano; Kim, Hyun W.; Thieker, David; Sheikh, M. Osman; Gas-Pascual, Elisabet; Rahman,Kazi; Zhao, Peng; Daniel, Nitin G.; van der Wel, Hanke; Ichikawa, H. Travis; Glushka, John N.; Wells, Lance; Woods, Robert J.; Wood, Zachary A.; West, Christopher M.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2020, JUL 3; 295(27): 9223-9243.
  1. 2.   Characterization of a cytoplasmic glucosyltransferase that extends the core trisaccharide of the Toxoplasma Skp1 E3 ubiquitin ligase subunit
  2. Rahman, Kazi; Mandalasi, Msano; Zhao, Peng; Sheikh, M. Osman; Taujale, Rahil; Kim, Hyun W.; van der Wel, Hanke; Matta, Khushi; Kannan, Natarajan; Glushka, John N.; Wells, Lance; West, Christopher M.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2017, NOV 10; 292(45): 18644-18659.
  1. 3.   The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Mercer, N.; Dulcey, A. E.; Griffiths, G. L.; Qasba, P. K.
  3. Glycobiology. 2012, Mar; 22(3): 379-388.
  1. 5.   Galectin-1 as a fusion partner for the production of soluble and folded human beta-1,4-galactosyltransferase-T7 in E. coil
  2. Pasek, M.; Boeggeman, E.; Ramakrishnan, B.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2010, Apr; 394(3): 679-684.
  1. 6.   Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method
  2. Boeggeman, E.; Ramakrishnan, B.; Kilgore, C.; Khidekel, N.; Hsieh-Wilson, L. C.; Simpson, J. T.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2007, May-Jun; 18(3): 806-814.
  1. 7.   Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Aaps Journal. 2006 8(1): E190-E195.
  1. 8.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 9.   Substrate-induced conformational changes in glycosyltransferases
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Trends in Biochemical Sciences. 2005, JAN; 30(1): 53-62.
  1. 10.   The role of tryptophan 314 in the conformational changes of beta 1,4-galactosyltransferase-I
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Journal of Molecular Biology. 2003 331(5): 1065-1076.
  1. 11.   beta-1,4-galactosyltransferase and lactose synthase: Molecular mechanical devices
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2002 291(5): 1113-1118.
  1. 12.   Crystal structure of beta 1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site
  2. Ramakrishnan, B.; Balaji, P. V.; Qasba, P. K.
  3. Journal of Molecular Biology. 2002 318(2): 491-502.
  1. 14.   Active site studies of bovine alpha 1 -> 3-galactosyltransferase and its secondary structure prediction
  2. Shah, P. S.; Bizik, F.; Dukor, R. K.; Qasba, P. K.
  3. Biochimica et Biophysica Acta - Protein Structure & Molecular Enzymology. 2000 1480(1-2): 222-234.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel